With genetic analyses it is possible to assess the activity of enzymes. We usually arrange analyses of detoxifying enzymes such as Cytochrome P 450 family, CYP, Superoxiddismutase, SOD, Glutathion-S-Transferase, GST, N-Acetyltransferase, NAT, Methylen Tetra Hydro Folat Reductase, MTHFR, just to mention a few.

These enable the assessment of aetiological factors of neurotoxic diseases such as MCS (multiple chemical sensitivity), and many others, as regards the patient’s detoxification capacity.

If, for example, the MTHFR mutates at one or both genetic positions, i.e. as opposed to a natural healthy state, it will cause functional damage to the activity of the enzyme.

This would explain an increase in the homocystein level or risk of thrombosis. Furthermore, an activation of folinic acid and cobalamin (methylation) then becomes constricted, thus rendering it necessary to administer activated vitamins in the form of folinic acid and methylcobalamin.

It is only then that therapeutic neuroprotective and methylation-detoxifying effects can be achieved.